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ABBREVIATIONS

DENV

Dengue virus

DENV-1

Dengue virus type 1

DENV-2

Dengue virus type 2

DENV-3

Dengue virus type 3

DENV-4

Dengue virus type 4

ml

Milliliters

µl

Microliters

PCR

Polymerase chain reaction

RACE

Rapid amplification of cDNA ends

RdRp

RNA-dependent RNA polymerase

RNA

Ribonucleic acid

UTR

Untranslated regions

1. Abstract
Dengue is one of the mosquito-borne diseases of major importance in public health,
which has spread worldwide, especially in tropical and subtropical regions, as a result of
globalization, precarious urbanization, and expansion of the mosquito vector. Although
it has been extensively studied at the molecular level, most of the dengue virus (DENV)
genomes at public databases lack or have uncorroborated ends of the untranslated regions
(UTRs), becoming a limitation when conducting studies of association between the
genetic background of the virus and the clinical outcome of the disease. In an attempt to
solve this problem, the present study aims to characterize the 5' and 3' ends of dengue
virus, to provide complete information for future studies of viral pathogenesis. The 5´
UTRs of twenty-seven Colombian DENV isolates (from patients with or without
warning signs or severe disease) were readily amplified through a standard RACE
approach while the 3´ UTRs required the development of a modified RACE protocol,
For the cDNA synthesis of the 5' UTR, a specific anti-sense primer for each serotype
was used, which were located at the coding region of the C or prM/M proteins. The
cDNAs were purified and subsequently polyadenylated using the terminal transferase.
By using an oligodT and an internal reverse primer located upstream of the first primer
used for cDNA synthesis, the 5' UTRs were successfully PCR amplified and sequenced.
For the molecular characterization of the 3' UTR, an adenine tail was directly added to
the positive-sense viral RNA using the E coli poly (A) polymerase, which allowed the
hybridization of the oligo-dT for the synthesis of cDNA, subsequent PCR amplifica tio n
and Sanger sequencing. The results allow to demonstrate the successful characteriza tio n
of the whole dengue virus UTRs and to assess the potential impact of point mutations at
the RNA secondary structure level.

Keywords: Genome ends, sequencing, dengue virus, RACE, E. coli Poly (A) polymerase.

2. Introduction
Dengue is considered to be one of the most important arthropod borne pathogens, since the
number of infected individuals has increased in the last two decades (Brathwaite Dick et al.,
2012). It has been estimated that 50 to 100 million infections occur worldwide each year; In
addition, infections occur in approximately 100 countries in the Asian-Pacific region,
Americas, Middle East and Africa (Brathwaite Dick et al., 2012; WHO, 2009). Dengue may
manifest in the host in two ways; Asymptomatic and symptomatic, the former may be
presented as DF (Dengue Fever), Dengue Hemorrhagic Fever (DHF) or Dengue Shock
Syndrome (DSS), or dengue without or with warming signs and severe dengue, according to
the more recent WHO classification (WHO, 2009). Currently, other atypical manifestatio ns
involving the damage of body organs or systems known as "severe forms of dengue with
organ compromise" and frequently associated with extreme severity and death are
recognized (Salgado, 2008).
Dengue virus (DENV) is transmitted through the bite of infected female mosquitoes
belonging to the genus Aedes, mainly Aedes aegypti, which is distributed in tropical and
subtropical countries, where about 3.6 billion people live (Rodriguez-Roche & Gould, 2013).
The life cycle of the DENV begins when the mosquito feeds on the blood of an infected
person, generating the infection of the mosquito midgut epithelial cells; then, the viral
particles generated in these cells are released to invade other organs such as the salivary
glands; The infection of the human host occurs when the mosquito injects its salivacontaining DENV particles during the blood meal (Velandia & Castellanos, 2011).
DENV is a serocomplex of four globally distributed and closely related species (serotypes
DENV-1, -2, -3 and -4) belonging to the family Flaviviridae, genus Flavivirus (Lindenbac h
et al., 2013; (Twiddy et al., 2002). Its genome consists of a positive-sense single-stra nded
RNA of about 11 Kb, which encodes for three structural (capsid, pre-membrane and
envelope) and seven nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5)
proteins (Guzman et al., 2010). At the 5' and 3' untranslated regions (5’ and 3’ UTR,
respectively), the DENV genome contains several evolutionarily conserved structural
elements involved in viral protein synthesis, genome replication and pathogenesis (Bäck &
Lundkvist, 2013; Chiu, Kinney, & Dreher, 2005; Hussain & Asgari, 2014; Yu, Nomaguchi,
Padmanabhan, & Markoff, 2008).

The 5' UTR has a length of 95 to 101 nucleotides and contains two structural domains, the
stem-loop A (SLA) and the stem-loop B (SLB) (Selisko, Wang, Harris, & Canard, 2014), in
addition to the 5' UAR (5’ upstream AUG region) element that is complimentary to the 3'
UAR during genome circularization. Two regions of the SLA domain interact with the viral
RNA-dependent RNA polymerase (RdRp) promoting viral RNA synthesis. The SLB domain
contains a 16-nucleotide-long (5’ UAR) that together with the 5’ cyclization sequence (5’
CS) is involved in genome cyclization, an essential process for viral replication (Filomato r i,
Iglesias, Villordo, Alvarez, & Gamarnik, 2011; Friebe & Harris, 2010).
Moreover, the 3' UTR comprises a stretch between 384 and 462 nucleotides and lacks of a
poly (A) tail. It is composed of three domains (I, II and III). The domain I, also known as
variable region (VR) extends about 50 to 120 nucleotides and is located just after the
polyprotein stop codon (Zhou et al., 2006). It was recently reported that this region contains
a viral miRNA with a role in DENV autoregulation in C6/36 cells by targeting the coding
sequence of the viral NS1 protein (Hussain & Asgari, 2014). The domain II includes a DB
(Dumbbell) structure with a double tandem repeat containing the conserved sequences CS2
and RCS2 (repeated CS2), these conserved sequences were proposed to be involved in viral
translation and RNA synthesis (Gebhard, Filomatori, & Gamarnik, 2011). Finally, the
domain III is the most conserved region of the DENV 3' UTR and contains two elements.
The first one is the 3' conserved cyclization sequence (3’ CS), a short element of 11
nucleotides complementary to the 5' CS located at the capsid-coding sequence (Filomato r i
et al., 2011). The second one is the 3’ stem-loop structure (3' SL) with approximately 79
nucleotides in length (Paranjape & Harris, 2010). This element contains the 3' UAR sequence
which is complementary to the 5' UAR at the 5' UTR. Both elements (3’ CS and 3’ SL)
promote the genome circularization through base pairing with its complimentary 5’ sequence
enabling the binding DENV and host proteins implicated in genome replication and protein
translation.
Although the genome of DENV has been extensively studied at the molecular level, most of
the available

whole-genome

DENV sequences at GenBank

have

incomplete

or

uncorroborated 5´ and 3´ UTRs due to limitations in the conventional techniques of reverse
transcription and subsequent PCR amplification, which involves the use of oligonucleotides
with known consensus sequences. In addition, the lack of a poly (A) tail at the 3’ UTR
hinders the use of most of the commercially available kits for amplification of 3’ UTR
sequences based on the oligodT complementarity.

Given the critical role of the 5’ and 3’ UTRs in DENV biology, the uncertainty of these
regions becomes a constraint for studies involving full-genome comparisons, identifica tio n
of genetic diversity and their potential role in pathogenesis and severe disease. Here, we
present a strategy for reverse transcription and PCR amplification of the complete 5' and 3'
UTRs of the four DENV serotypes, its performance in positive viral isolates of dengue from
passage 2 and discuss the relevance of nucleotide substitutions at the secondary structure
level.

3. Objectives
3.1. General objective
To standardize and implement the characterization of the 5' and 3' UTRs of the genome
of dengue virus serotypes 1, 3 and 4, as a potentially useful tool in studies of viral
pathogenesis.

3.2. Specific objective


To characterize the 5' and 3' UTRs of the genome of 15 DENV strains isolated from
patients with dengue and severe dengue in Colombia, by rapid amplification of
cDNA ends (RACE) and direct Sanger sequencing.



To evaluate alterations in the secondary RNA structure of the 5' and 3' UTR of the
dengue virus genome, caused by point mutations in Colombian strains.

4. Materials and methods
4.1.Cell cultures and viral isolation
Human sera from DENV-infected patients were diluted (1/100) in Eagle´s Minimal Essentia l
Medium (E-MEM) supplemented with 1% HEPES, 1% NaHCO 3 , 5% Tryptose and 2% fetal
bovine serum. Subsequently, C6/36 cell monolayers were inoculated with 200 µL of each
diluted serum. Viral adhesion was carried out at 28 °C in a 5% CO 2 atmosphere during 1
hour, afterwards 800 µL of supplemented E-MEM were added. The cultures were incubated
at 28 ºC, 5% CO 2 atmosphere until cytopathic effect (CE) typically syncytia or cell growth
arrest was observed without exceeding 14 days. A second passage for samples without
showing CE was performed by transferring a 200 µL aliquot of the cell supernatant from the
first passage to a fresh C6/36 monolayer. Culture supernatants were collected, cleared,
aliquoted and stored at -80ºC.

4.2. Viral RNA extraction
The commercial QIAamp Viral RNA Mini Kit (Qiagen®, Chatsworth, CA, USA) was used
for viral RNA extraction by following the manufacturer's recommendations. Briefly, a
volume of 140 μl of each serum sample or cell culture supernatant (viral isolation) was mixed
with 560 μl of AVL buffer containing carrier RNA. Then, 500 μl of absolute ethanol were
added and the total volume transferred to a silica gel-based mini spin column and centrifuged
at 8000 rpm. Subsequently, two washing steps were performed by adding 500 μl of AW1
buffer and 500 μl of AW2 to remove residual contaminants by centrifuging at 8000 and
13000 rpm, respectively. Finally, the elution was performed by the addition of 60 μL of AVE
buffer to the column, incubating for 1 min at room temperature and centrifuging at 8000 rpm
for 1 min. The purified RNAs were used for DENV serotyping in the virology laboratory of
the National Institute of Health; using nested RT-PCR using improved oligonucleotides
(Usme, Gómez, & Gallego, 2012), and stored at -70°C for subsequent cDNA synthesis.
4.3. Primer designing for amplification of the DENV 5′ and 3′ untranslated regions (UTRs)
Following the 5'/3' RACE kit 2nd generation (Roche Diagnostics GmbH, Mannheim,
Germany) manufacturer´s recommendations, three specific antisense (SP1, SP2 and SP3)
and two sense (SP4 and SP5) primers were designed for cDNA synthesis and PCR

amplification of the 5' and 3' UTR regions of all DENV serotypes. Primer design was carried
out using the parameters described in Table 1, through the PrimerSelect module of the
LaserGene® suite version 8.1 (DNASTAR Inc., Madison, WI, USA.). The genomic
sequences of four DENV isolates GQ868568 (DENV-1), NC_001474 (DENV-2),
GU131954 (DENV-3) and GQ868585 (DENV-4) were used as reference. Once the best
primer candidates were identified, they were aligned against several DENV strains reported
in South American countries (Brazil, Peru, Venezuela, Ecuador, Argentina, Chile and
Paraguay), in order to assess and consider the genetic variability from this region. The
primers were finally designed by following parameters such as the 3'-OH of the primer
coincident with the second or first codon position (for those located in the coding region),
the inclusion of degenerate sites for those nucleotide positions with representative variability
of DENV strains through the South American region. Degenerate sites were introduced
according

to

the

IUPAC

nucleotide

ambiguity

code,

available

at:

http://www.chick.manchester.ac.uk/SiteSeer/IUPAC_codes.html.
The use of the previously designed anti-sense primers extending through the C or prM/M
coding region (between positions 298 and 579, respect to each reference sequence) allowed
the successful amplification of the 5' end of Colombian DENV-2 strains. Sense primers
extending from the NS5 coding region and the 3’UTR (between positions 10114 and 10333,
respect to each reference sequence)

were successfully

used for the molecular

characterization of the 3' end. The PCR products were easily visualized through agarose gel
electrophoresis showing a specific amplification that, allowed the direct purification and
sequencing.
Table 1. Characteristics that were considered for the design of the primers for the
amplification of the amplification of the 5' and 3' UTR ends.
Characteristics

Length primers
Melting
Stability 3' pentamer
unique sequence in the 3'

Minimum
17 bp
35.8ºC
8.5 -Kc/M
7 bp

Maximum
24 bp
62.5ºC

4.4. Reverse transcription and PCR amplification of the 5´ untranslated region
Serotype specific anti-sense primer SP1 (12,5 pmol), 5 µL (100-200ng) of total RNA
extracted from DENV infected C6/36 cell supernatants, 1 mM dNTPs, 25 U Transcriptor
Reverse Transcriptase (Roche Diagnostics GmbH, Mannheim, Germany), 1X cDNA
synthesis buffer and 5 U RNaseOUT (Life Technologies, Carlsbad, CA, USA) were used for
the cDNA synthesis of the 5' end. The mixture was incubated for 60 min at 55°C, then,
reverse transcriptase was inactivated by heating at 85°C for 5 min. The cDNA products were
purified using QIAquick PCR Purification Kit (Qiagen®, Chatsworth, CA, USA) following
the manufacturer´s instructions.

Poly (A) tailing of the first-strand cDNA using a

recombinant terminal transferase and PCR amplification of dA-tailed cDNA were performed
according to the 5'/ 3' RACE kit 2nd generation manufacturer’s instructions. The expected
sizes of the PCR products generated with the SP2 primer were 453, 380, 448 and 477 for
DENV1, 2, 3 and 4 respectively; while for the SP3 primer expected sizes were 310, 300, 298
and 321 for DENV1, 2, 3 and 4 respectively.

4.5. Poly A tailing reverse transcription and PCR amplification of the 3´ untranslated
region
In view that RNA extracts from infected cell supernatants contain nearly exclusive ly
positive-sense DENV genomes and the DENV genome lacks of a poly (A) tail, it is not
possible to use specific forward primers (SP4 or SP5) or oligo-dT for cDNA synthesis.
Therefore, the strategy consisted in the direct adenylation of positive-sense DENV RNA
genomes Briefly, 15 µL of total RNA (~500ng) were poly-adenylated at the 3' end in a
reaction mixture containing 0.5 units of E. coli poly (A) polymerase system (New England
Biolabs), E. coli poly (A) polymerase reaction buffer (50 mM Tris-HCl, 250 mM NaCl, 10
mM MgCl2) and 1mM adenosine-5'-triphosphate (ATP) followed by incubation 37°C for 30
minutes. Afterwards, 5 µL from the previous reaction were used in cDNA synthesis reaction
using high capacity cDNA reverse transcription kit (Applied Biosystems) the reaction mix
included 12.5 pmol of the oligo-dT anchor primer (5’-GAC CAC GCG TAT CGA TGT
CGA C-TTT TTT TTT TTT TV-3’), 1X RT-buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.3),
1mM dNTPs, 50 U MultiScribe™ reverse transcriptase and 5 units of RNaseOUT. The
reaction mix was incubated at 58°C for 45 min, then 85°C for 5 min. Next, the PCR step was
performed using 5 µL from the previous reaction, 37.5 pmol of oligo-dT, anchor primer 12.5

pmol of serotype-specific SP5 primer, 1.25 U Taq DNA polymerase (Thermo Fisher
Scientific, Carlsbad, CA, USA), 1X PCR buffer, (20 mM Tris-HCl pH 8.4, 50 mM KCl), 2
mM MgCl2, 1mM dNTPs and nuclease-free water for a final volume of 50 μL. The mixture
was incubated at 95°C for an initial 5 min denaturation step, followed by 45 cycles (95°C
for 30 sec, 50°C for 30 sec, 72°C for 90 sec), and a final extension at 72°C for 5 min. It was
used in the PCR, sterile water as negative control and as a positive control it were used strains
of each serotype previously typified of dengue virus. The expected sizes of the PCR products
generated with the SP4 primer were 713, 563, 490 and 452, for DENV1, 2, 3 and 4,
respectively, while for the SP5 primer the expected sizes were 581, 438, 389 and 389, for
DENV1, 2, 3 and 4, respectively.
4.6. DNA sequencing and sequence handling
PCR products were purified by using the QIAquick PCR purification kit (Qiagen® ,
Chatsworth, CA, USA) and the expected sizes confirmed by agarose gel electrophores is.
Around 40 ng of each purified amplicon were added to a sequencing reaction mixture
containing 3 µL of BigDye® terminator cycle sequencing v3.1 (Applied Biosyste ms,
Carlsbad, CA, USA), 3.2 pmol of the serotype-specific oligonucleotide, and 2 µL of 5X
sequencing buffer (400 mM Tris-HCl, 10mM MgCI2 ), in a final volume of 10 µL. The
thermal profile consisted of an initial denaturation step at 96°C for 1 min, followed by 25
cycles (96°C for 10 sec, 50°C for 5 sec, 60°C for 4 min); The DNA fragments were purified
through the BigDye® Xterminator purification kit (Applied Biosystems, Carlsbad, CA,
USA), and subsequently processed by the ABI 3130 Genetic Analyzer (Applied Biosyste ms,
Carlsbad, CA, USA). The electropherograms were visualized, edited and assembled through
the SeqMan module of LaserGene® v8.1 (DNASTAR Inc., Madison, WI, USA.).
4.7. Sequence alignment and evolutionarily-conserved RNA structure prediction
Homologous sequences were aligned through the ClustalW algorithm implemented in
MEGA version 7 (Kumar, Stecher, & Tamura, 2016). For comparison, some availab le
complete genomes of the different serotypes of DENV circulating in South America were
included in the analysis. The Basic Local Alignment Search Tool (BLAST) was used to
verify the similarity of the obtained sequences in the present study. The Colombian
sequences corresponding to the 5′ and 3′ UTR of each DENV serotype were used for
prediction of secondary structures and the identification of evolutionarily-conserved RNA
elements,

through the use of RNAstructure and RNAz web servers, available at

http://rna.urmc.rochester.edu/RNAstructureWeb/

and

http://rna.tbi.univie.ac.at/c gi-

bin/RNAz/RNAz.cgi, respectively; on the other hand, the RNAfold software was used as a
tool to have a general overview of the pertaining secondary structures at the DENV UTR,
available at http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi.

5. Results
5.1. Amplification of the 5' UTR of all DENV serotypes
Following the strategy described in Materials and Methods, serotype-specific primers (SP1,
SP2 and SP3) were designed for amplification of the 5' end of the DENV genome (Table 2).
The 5' UTR of Colombian strains corresponding to the four DENV serotypes was
successfully

amplified

by using

the standard RACE approach that involved

the

polyadenylation of the cDNA generated with the primer SP1 (Figure 1a), However, in the
first round of PCR amplification (with serotype-specific primer SP2), bands of the expected
size were only observed for isolates of DENV-2 and -3. While in the second PCR round
(with serotype-specific primer SP3), bands of the expected size were observed for all DENV
serotypes. (Figure 2). The cycling conditions consisted of an initial denaturation at 95°C for
2 min, 40 cycles of denaturation (95°C for 20 sec), annealing (30 sec at 58°C for DENV-1
and DENV-3) or 50°C for DENV-4), and extension (72°C for 30 sec), with a final extension
at 72°C for 7 min.
Table 2. Serotype-specific primers used for amplification and sequencing of the 5' and 3'
ends of the DENV genome.
Serotype

DENV-1

Primer
name

Orientation

Region

Genomic
position a

Anti s ens e
Anti s ens e
Anti s ens e
s ens e
s ens e

5´
5´
5´
3´
3´

560-579
431-453
287-310
9949 – 9970
10119 - 10140

CCGGGGGCATTTGTAGGTCA
TATCATGTGTGGCTCTCCYCCTC
CTTTGATYGCTCCATTCTTCTTGA
CACCAATGGATGACAACAGAAG
CACCTGGGCCACCAACATACAA

59.1ºC
54.7ºC
56.5ºC
51.9ºC
59.1ºC

Sens e
Sens e

3´
3´

10114-10137
10238-10262

AGAACATCCAAACAGCAATAAATC
AAGGGAAGAGGAAGAGGCAGGTGT

59.0ºC
61.8ºC

DENV1_SP1
DENV1_SP2
DENV1_SP3
DENV1_SP4
DENV1_SP5

Anti s ens e
Anti s ens e
Anti s ens e
s ens e
s ens e

5´
5´
5´
3´
3´

560-579
429-448
276-298
10210-10233
10311-10333

GGTRATRTGGGGGCATTTGTAAG
CGGCTCTCCATCTCGTGAAG
CGACTTCTTGAAGGTTCCCCATC
GAAGGAGGAGGARTCGGAGGG
GCCTGTGAGCCCCGTCTAAG

53.6ºC
54.7ºC
57.7ºC
55.7ºC
56.1ºC

DENV1_SP1
DENV1_SP2
DENV1_SP3
DENV1_SP4
DENV1_SP5

Anti s ens e
Anti s ens e
Anti s ens e
s ens e
s ens e

5´
5´
5´
3´
3´

496-517
454-477
298-321
10302-10320
10098-10120

TTGTTGATCCCCTCTGTTGTYT
CCCTTTCATGTTTTGCCACTATCA
GTGGGATGGAAAGRACTCGCA
GCAAACCGTGCTGCCTGTA
GGACTTTCTTCYAGAGCCACCTG

52.6ºC
56.9ºC
58.5ºC
54.5°C
53.2ºC

DENV1_SP1
DENV1_SP2
DENV1_SP3
DENV1_SP4
DENV1_SP5

DENV-2c DENV2_SP4
DENV2_SP5

DENV-3

DENV-4

a

Sequence (5´- 3´)b

TM

Genomic positions were estimated for every DENV serotype according to the sequences
available in GenBank with accession numbers: GQ868568 (DENV-1), NC_001474
(DENV-2) GU131954 (DENV-3) and GQ868585 (DENV-4). b Degenerate sites were
included by following the IUPAC nucleotide ambiguity code. c DENV-2 primers were
designed in a previous study by Laiton-Donato 2016.

Fig. 1. Strategy for polyadenylation, cDNA synthesis and PCR amplification of the 5' and 3' ends of the DENV
genome. a). Terminal transferase-based protocol for amplification of the 5´ end b). Poly (A) polymerase-based
protocol for amplification of the 3´ end. V: A, C or G. adapted from the 5'/3' RACE kit 2nd generation

(Roche Diagnostics GmbH, Mannheim, Germany).
5.2. Amplification of the 3´ UTR of all DENV serotypes
For cell-free supernatants of infected C6/36 cells, the standard RACE approach was not
expected to be an efficient method for the characterization of the DENV 3' UTR, because of
the exclusive presence of positive-sense RNA genomes in the secreted viral particles. A first
approach to overcome this limitation, consisted in applying the RACE strategy to total RNA
extracts obtained from cell lysates, in which the presence of negative-sense viral RNA within
dsRNA and replicative intermediates is expected (Chu & Westaway, 1985). This strategy
was not successful (data not shown), possibly due to the asymmetric replication of the DENV
genome, and therefore the low abundance of negative-sense viral RNA strands (Diamond,
Edgil, Roberts, Lu, & Harris, 2000). A second and novel approach consisted in the polyadenylation of the positive-sense viral RNA by using the E. coli poly (A) polymerase, and
subsequent oligo-dT hybridization on the artificially generated poly (A) tail (Figure 1b),
which demonstrated to be successful for specific amplification of the 3' UTR of DENV -2, 3 and -4. (Figure 3). The cycling conditions that were standardized for each serotype
consisted of an initial denaturation of 95°C for 2 min, 30 cycles of denaturation at 95°C for
20 sec, annealing for 30 sec at 52°C for DENV-2, 61°C for DENV-3 and 52°C for DENV4, and extension at 72°C for 30 sec), with a final extension at 72°C for 7 min, in case of
DENV -3 and -4 were 40 cycles. DENV-1 strains were not.

At the best of our knowledge, this novel poly (A) polymerase-based approach has not been
previously used for molecular characterization of the 3’ UTR of positive-sense viral RNA
genomes.

Fig. 2. PCR amplification of the 5´end of dengue virus serotypes 1, 3 and 4. a), b) and c) Nested
PCR using SP2 or SP3 and oligodT anchor primers for successful amplification of DENV-1, -3
and -4 strains, respectively. Previously characterized DENV strains were used as positive
controls. The PCR product was 453, 448 and 321 bp in length for DENV-1, -3 and -4, respectively.
MW: 100 bp DNA ladder (Invitrogen) were used in a) and b) with 600 bp and the PCR product
of each serotype marked; on the other hand, c) 100 bp DNA ladder (Thermo Fisher) was used
with 500 bp and the PCR product marked.

Fig. 3. PCR amplification of the 3´end of dengue virus serotypes 2, 3 and 4. a), b) and c). Nested
PCR using SP4 and oligodT anchor primers for successful amplification of DENV-2, -3 and -4
strains, respectively. Previously characterized DENV strains were used as positive controls. The
PCR product was 563, 490 and 452 bp in length for DENV-2, -3 and -4, respectively. MW:
GeneRuler 100 bp DNA ladder (Thermo Fisher) with 500 bp and the PCR product of each
serotype marked.

5.3. Molecular characterization of the 5' and 3' ends of the dengue virus genome
The DENV 5´ and 3´ end sequences were obtained by Sanger sequencing with specific
primers (SP2, SP3, SP4 or SP5), as no good quality sequences were obtained with oligo- dT
primer as expected from the variable size of the poly (A) tract among DNA molecules. A
total of 31 isolates from Colombian clinical samples were successfully sequenced, 26
isolates belonged to patients with dengue without warning signs (3 from DENV-1, 10 from

DENV-2, 10 from DENV-3 and 3 from DENV-4) and 5 from severe dengue patients (all
from DENV-2) (Table 3). The electropherograms allowed to confirm the presence of the
artificially generated poly (A) tail (Figure 4). Currently available full- length genomes of
Colombian DENV isolates available at GenBank have incomplete or uncorroborated 5’ and
3´ ends, typically lacking the first or last ~20 nt at the 5´ and 3´ ends, respectively. Using the
BLAST alignment tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) the sequences obtained in
the present study matched with other DENV strains reported in American countries (Cuba,
Haiti, Brazil, Peru, Venezuela, Ecuador, French Guiana, Argentina, Chile and Paraguay).
Even though our approach yielded sequences of the 5’ and 3’ ends for most of the tested
isolates, four isolates showed a shorter amplicon size at the 5´end characterized by the
presence of the poly (A) tract at the position 134 (relative to the reference sequence
NC_001474). Interestingly the isolates that showed this behavior also, showed a noticeable
drop in the fluorescence signal in the electropherograms, from that position to the beginning
(position 1 of the viral genome).
Table 3. List of DENV-1, -2, -3 and -4 strains included in the study and associated clinica l
characteristics.

Serotype

Code

Strains

Year

Department

UTR
sequenced

Clinical
classification

DENV 1

424735
427493
450339

58
61
69

2013
2013
2015

META
TOLIMA
CUNDINAMARCA

5´
5´
5´

DF
DF
DF

423887
427516
425334
425817
425819
428702
424233
449418
449308
449618
449510
434321

12
28
41
44
46
56
59
62
66
67
68
156

2013
2013
2013
2013
3013
2014
2013
2015
2015
2015
2015
2014

PUTUMAYO
CALDAS
PUTUMAYO
TOLIMA
CUNDINAMARCA
TOLIMA
BOYACÁ
TOLIMA
HUILA
HUILA
PUTUMAYO
META

3´
3´
3´
3´
3´
3´
5´ / 3´
5´
5´ / 3´
5´
5´
3´

DF
DF
DF
DF
DF
DF
DF
DF
DHF/mortal
DF
DF
DF

449683
449499
449415
449740
449746
449255
449326
449334
449335

57
60
63
81
82
84
85
86
87

2015
2015
2015
2015
2015
2015
2015
2015
2015

RISARALDA
RISARALDA
PUTUMAYO
SUCRE
RISARALDA
QUINDÍO
RISARALDA
BOYACÁ
BOYACÁ

5´ / 3´
5´ / 3´
5´ / 3´
5´ / 3´
5´ / 3´
5´ / 3´
5´ / 3´
5´ / 3´
5´ / 3´

DF
DF
DF
DF
DF
DF
DF
DF
DF

DENV 2

DENV 3

Access
number

DENV 4

371813
37178
426553

88
89
90

5´ / 3´
5´ / 3´
5´ / 3´

Fig.4. Artificial polyadenylation at the 5' and 3' ends of the DENV genome. Electropherograms of
the 5´ and 3´ends of representative strains of DENV-1 to DENV-4. The 5’ and 3’ ends were
sequenced by using specific reverse and forward primer, respectively.

5.4.Evolutionarily conserved structural elements at the 5´ and 3´ untranslated regions of
dengue virus
The two highly conserved secondary structures corresponding to the stem-loop A (SLA) and
SLB were identified at the 5´ UTR, as well as the conserved RNA elements 5' UAR and 5'
CS. In addition, it was possible to identify and the cHP element extending to the capsidcoding region (Figure 5A); On the other hand, at the 3' UTR the 3´ SL, DB1 and DB2
secondary structures were found with their respective conserved sequences RCS2 and CS2;
in this region we also found the variable region and the conserved 3' UAR and 3' CS (Figure
5B).

FIG.5. RNA structure elements at the DENV 5 ' and 3' UTR. A) Elements present at the 3’ UTR. B) Element s
at the 5´ UTR.

At the 5' UTR of DENV, the structure analyzes of the DENV-2 5´end of the strains that
showed the late poly-A tail and which generated shorter sequences, were not able to obtain
the secondary structures present in the 5´ end, since, when analyzing the late poly (A) tail
was found in the position 134 which is after SLA and SLB structures, curiously, the position
of the late poly (A) was the same in all four strains, although, , when the amplification test
was repeated with a high fidelity Taq polymerase, bands with a smaller size than expected
were obtained. On the other hand, two thermodynamically stable secondary structures were
identified in serotypes 1, 3 and 4.The first structure corresponds to the SLA element and the
second structure corresponds to the SLB element (Figure 6).
5´ UTR
(A) DENV 1

SLB

(B) DENV 3

SLA
SLB

(C) DENV 4

SLB
SLA

Fig 6. Alignment and secondary structures present in the 5'utr region of DENV. A) alignment and
structure of the SLA and SLB elements of DENV 1, B) alignment and structure of SLA and SLB
elements of DENV 3 and C) alignment and structure of SLA and SLB elements of DENV 4.

On the other hand, in the 3'UTR region, the DB2 and 3'SL elements were identified for
serotypes 2, 3 and 4 (Figure 7). For all elements analyzed in both the 5'UTR region and the
3'UTR, different parameters were determined that are related to their thermodyna mic
stability Table 4.
3´ UTR
A) DENV 2

DB2

3´SL

B) DENV 3

DB2

3´SL

C) DENV 4

DB2

3´SL

Fig 7. Alignment and secondary structures present in the 3' UTR region of DENV. A) Alignment and
structure of the DB2 and 3´SL elements of DENV 2, B) Alignment and structure of DB2 and 3´SL elements
of DENV 3 and C) Alignment and structure of DB2 and 3´SL elements of DENV 4.

Table 4.
Thermodynamic stability of the secondary structures present in the 5' and 3' UTR of DENV -1, -2, -3
and -4.
Paramete rs

DENV 1
SLA

DENV 2

SLB

DB2

3´SL
160280

DENV 3
SLA

DENV 4

SLB

DB2

3´SL

SLA

SLB

DB2

3´SL

0-124

0-124

120240

163283

0-120

0-120

120-240

200-320

Location

0-120

0-120

80200

Length

120

120

120

120

120

120

120

120

120

120

120

120

93.75

93.75

99.00

98.67

98.87

98.87

99.0

98.25

99.44

99.44

100.00

94.17

0.00

0.00

-0.16

-0.16

-0.40

-0.40

0.00

0.00

0.00

0.00

0.00

1.48

-2.27

-2.27

-1.64

-3.89

-2.31

-2.31

-1.27

-3.99

-2.90

-2.90

-2.38

-2.28

0.84

0.84

0.99

0.99

1.01

1.01

1.00

1.00

1.00

1.00

1.00

0.94

Mean
pairwise
identity
Covariance
contribution
Mean
z-score
Structure
conservation
index

5.5. Coverage at the 5' and 3' ends of the DENV genome in previously reported sequences
In order to assess the coverage at the 5’ and 3’ ends, previously reported sequences of DENV
strains circulating in neighboring countries (Brazil, Peru, Venezuela, Ecuador, Argentina,
Chile and Paraguay) were aligned with those of the present study. At least 20 nucleotides
are missing in the previously published sequences and were successfully sequenced through
the methods described here (Figure 8). At the 3’ end, the last nucleotide is called “N” to
designate a variable position, this is a consequence of using a degenerate oligo-dT anchor
primer containing A, C or G at the 3’ end (Figure 8B). At the 5’ end, the “N” is also present
at the -1 position, therefore, it does not affect the sequence of interest (Figure 8A).

Fig.8. Alignment of sequences obtained with reported in GenBank database. a) Sequences belonging to the end amplification of the 5' UTR
region. b) Sequences belonging to the amplification of the 3' UTR region end.

6. Discussion
During the last two decades, the intense research in fundamental biology of DENV and other
closely-related flaviviruses has allowed deciphering the role or function of almost all viral
proteins during the virus life cycle. These studies have also allowed the identification of
several genome features that explain some of the phenotypic differences at the virus
replication or virus-host interaction and pathogenesis levels. Genome differences include the
presence/absence of nucleotide substitutions and insertion/deletions in the coding and the
untranslated regions. It has been shown that the replication capacity of a virus is
indispensable at the time of deciphering key elements in the pathogenesis and virulence. The
5´and 3´ UTR could harbor some important determinants of virulence (Leitmeyer et al.,
1999), for this reason, analyzing these regions through complete sequencing is mandatory.
The DENV RNA-dependent RNA polymerase endows the DENV genome with a high
mutation rate ranging from 4.5x 10-4 substitutions per site every year (s/s/y) for DENV-1 to
9x10-4 s/s/y for DENV-3, with some differences according to the serotype (Falcón-Leza ma
et al., 2009). The unavoidable accumulation of genetic variation in the whole DENV genome
suppose a challenge for sequence-based molecular methods and therefore justify the rational
design of degenerated oligonucleotides that theoretically cover the existent genetic
variability and perform well for a longer period of mutation accumulation. Here, we used
the PrimerSelect module of the LaserGene suite, which integrates the Nearest Neighbor
algorithm for ΔG and melting temperature (Tm, the temperature at which half of the
oligonucleotides have hybridized with the sequence) calculation. Using this algorithm, it was
possible to design primers that worked well at the time of amplifying and sequencing the 5'
and 3' ends of the DENV genome. All oligonucleotide candidates were analyzed through
sequence alignment to cover the existing variability of DENV strains across the region and
to avoid the use of critical primer positions according to the evolutionary behavior (e.g.
codon position); the criteria that were used in this design of primers have already been
validated previously in the study carried out by (Usme et al., 2012)
In this work we demonstrated the successful cDNA synthesis and PCR amplification of
several strains of the different DENV serotypes through the use of specific and sometimes
degenerated oligonucleotides. The strategy consisted in following the standard termina l
transferase-based RACE protocol for the 5’ end characterization.

The original RACE protocol for the 3’ end was intended to work directly with
polyadenylated RNA (e.g. messenger RNA), so in the case of DENV it was necessary to
attach a poly (A) tail at this end. Therefore, a novel approach for the 3’ end characteriza tio n
was implemented using the E. coli poly (A) polymerase, which was based on the direct
polyadenylation of the positive-sense viral RNA genomes previously extracted from
supernatants of infected cells. The artificially generated poly (A) tail provided a target for
the oligo-dT hybridization during the cDNA synthesis and subsequent PCR amplifica tio n
following the standard RACE protocol. High quality electropherograms evidenced the
successful incorporation of a poly (A) tract to the viral genome and the complete resolutio n
of the 3’ end sequence of the analyzes DENV strains of serotypes 2, 3 and 4. There were
technical problems for PCR amplification of the 3’ end of DENV-1, however, it was not
possible to attribute the cause to the primer design, because several oligonucleotide sets were
unsuccessfully used.
The technical approach presented here could be routinely used as a complement to fullgenome sequencing through different methods, by increasing the coverage at the genome
ends and allowing more accurate association studies to phenotypic characteristics.
The vast majority of Colombian DENV full- length genomes available at GenBank lack the
5' and 3' ends of the UTR, due to the limitations imposed by current RNA genome
amplification techniques by reverse transcription and PCR, which involves the use of
oligonucleotides with previously known sequences during cDNA synthesis or PCR
amplification; On the other hand, it has not been possible to establish an optimal method for
its amplification without the risk of losing the end (Christenbury et al., 2010). Next
generation sequencing (NGS) technologies such as reversible terminator sequencing- b ysynthesis by Illumina have shown to work well for the characterization of full-length RNA
genomes including the UTRs with a level of detail for analyzing viral quasispecies and the
presence of multiple genotype variants in a single sample, however, the computatio na l
methods for assembling Illumina short reads and solve homopolymeric regions at the DENV
UTRs are still challenging (Caraballo Cortes et al., 2016). Hence, the methods described
here offers a simple, straightforward and cost-effective way to characterize the most
representative UTR sequences of any DENV serotype.
It has been shown that there are factors associated with the virus that contribute in a
differential way to the development of the disease, known as determinants of virule nce.

These factors have been associated with the serotype and genotype of the virus and identified
as with point mutations that directly affect the viral fitness and therefore the levels of viremia
in the human host (Vaughn et al., 2000); Other studies suggest that virulence determina nts
are present randomly throughout the DENV genome (Daira Camacho et al., 2009; Daría
Camacho, Ferrer, Tenorio, Franco, & Comach, 2012), associated with the envelope gene or
located at the 5' and 3' UTR (Leitmeyer et al., 1999) where they are involved in the initia tio n
of translation (You & Padmanabhan, 1999), and in the regulation of viral replicatio n;
(Alvarez, De Lella Ezcurra, Fucito, & Gamarnik, 2005; Daira Camacho et al., 2009; Daría
Camacho et al., 2012; Rico-Hesse et al., 1997). It has been considered that the more virule nt
strains are those with greater replicative capacity (Vaughn et al., 2000), therefore, the in
vitro characterization becomes an indirect way of evaluating its capacity to cause disease.
In this work we modified the RACE protocol since, as already mentioned, this protocol
works directly with messenger RNA so in the case of DENV it was necessary to attach a
poly A tail at the 3' UTR end, with the enzyme E. coli Poly A polymerase was able to provide
a site for the synthesis of the cDNA using an Oligo-dT and in this way when binding by base
pairing with the Poly A tail it was possible to obtain the end of the non-coding 3' UTR region.
Due to the successful incorporation of the adenine tail, it was possible to implement the
RACE protocol and in this way to amplify and sequence the complete ends of the DENV.
A deletion of 11 nucleotides in the variable region (VR) was observed in 3 strains of DENV3; when comparing these sequences from Brazil, Nicaragua and Singapore, but not in
Colombian strains; Previous studies have demonstrated deletions and nucleotide variatio ns
in the (VR) within the same serotype (Aquino et al., 2006; Roche, Cassar, Laille, & Murgue,
2007); In spite of these observations, a high conservation was also found in the 5'UAR, 5'CS
elements present in the 5' UTR region and in the case of the 3' UTR two variations were
observed in the elements DB1 and DB2; On the other hand, the elements 3'SL, 3'UAR, 3'CS
were the most conserved, as expected, since these elements belong to domain III, which has
been considered the most conserved region at the 3´UTR. (Iglesias & Gamarnik, 2011).
When comparing the sequences of the elements present in the UTRs that were obtained in
this work with those found in the work of (Paranjape & Harris, 2010), it was found that both
the SLB and 3'SL elements as well as the sequences 5'UAR, 5'CS, 3'CS and 3'UAR remained
preserved; While in the elements SLA, cHP, and DB1 variations were found, just as in the
CS2 sequence present in the DB2 element; on the other hand, with the RNAz software it was

found that the structures analyzed for the 5' UTR region have an identity of ~ 97.18% at the
nucleotide level, in addition, two secondary structures denominated SLA and SLB were
shown in silico (Gebhard et al., 2011); In the 3' UTR region an identity of 98.18% was
found, in this region two structures denominated DB2 and 3'SL were evidenced (Gebhard et
al., 2011). Any mutation in regions that are highly structured such as UTRs could lead to
alterations in the structure and that previous studies are known to be very important at
functional level; this would explain why, no conformational changes were found in the
secondary structures encountered, or other additional structures.
At the time of analyzing the sequences of the 5' UTR ends of the four serotypes we found a
double peak in the sequences and a premature adenine tail; (Añez, Heisey, Volkova, & Rios,
2016) it was thought to be the result of the existence of a heterogeneous viral population that
contains two master sequences whit almost the same frequency and different length due to
insertion/deletion mutations.
The study presents a novel technical approach to the DENV genome ends characterizatio n,
which could contribute to the extension of the frontier of knowledge through the
identification of genetic determinants of pathogenicity that lead to severe manifestations of
dengue.
7. Conclusions
The methodology was successful for the amplification of the 5' and 3' UTR ends of the strains
to be analyzed, a total of 31 Colombian DENV isolates were identified, 26 from dengue
patients with no warning signs (3 from DENV-1, 10 from DENV-2, 10 from DENV-3 and
3 from DENV-4) and 5 from severe dengue DENV-2); of which, it was possible to solve the
complete ends of the DENV genome and to observe that although variations were found in
some sequential structures, they did not generate any change in the structure.
This study will provide new knowledge and an important tool for obtaining information from
the ends of the viral genome for the evaluation of the effect of mutations on the secondary
structure of RNA and its potential impact on viral replication and pathogenesis.
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